SCHEMBL26547987

SCHEMBL26547987

C[Si](C)(C)c1ccc(-c2ccc3cc(-c4ccc(-c5ccncc5)cc4)ccc3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.50
CYP19A1 P11511 2/20 0.47
CYP17A1 P05093 3/20 0.46
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
CYP3A4 P08684 1/20 0.45
CLK1 P49759 1/20 0.44
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
QDPR P09417 1/20 0.44
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
MAPK8 P45983 1/20 0.42
MAPK9 P45984 1/20 0.42
MAPK10 P53779 1/20 0.42
MAP4K4 O95819 1/20 0.42
CDK8 P49336 1/20 0.42
CLK2 P49760 1/20 0.42
CDK7 P50613 1/20 0.42
CDK9 P50750 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548408 1.00 DYRK1A (0.50) DYRK1ACYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL26548908 0.94 DYRK1A (0.49) DYRK1ACYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL26548593 0.94 DYRK1A (0.49) DYRK1ACYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL26548544 0.89 ESR1 (0.44) CYP19A1CYP17A1CYP11B1CYP11B2CYP3A4
SCHEMBL26548158 0.89 ESR1 (0.44) CYP19A1CYP17A1CYP11B1CYP11B2CYP3A4
SCHEMBL9612000 0.85 LMNA (0.61) DYRK1ACYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL26549019 0.83 ESR1 (0.46) DYRK1ACYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL26548674 0.83 ESR1 (0.46) DYRK1ACYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL13063101 0.82 ESR1 (0.55) CYP19A1CYP17A1CYP11B1CYP11B2CYP3A4
SCHEMBL26566383 0.82 CYP1A2 (0.47) CYP3A4PDGFRBPDGFRASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 DYRK1A 4709/4885CYP19A1 999/4885CYP17A1 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.